Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05382325 |
| Title | A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | NLD | ISR | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sanford Cancer Center ( Site 0005) | Sioux Falls | South Dakota | 57104 | United States | Details | |
| NEXT Oncology ( Site 0001) | San Antonio | Texas | 78229 | United States | Details | |
| Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0011) | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Rambam Health Care Campus-Oncology ( Site 0021) | Haifa | 3109601 | Israel | Details | ||
| Sheba Medical Center-ONCOLOGY ( Site 0020) | Ramat Gan | 5265601 | Israel | Details | ||
| Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 0035) | Amsterdam | Noord-Holland | 1066CX | Netherlands | Details | |
| Erasmus Medisch Centrum-Medical Oncology ( Site 0036) | Rotterdam | Zuid-Holland | 3015 GD | Netherlands | Details | |
| Universitair Medisch Centrum Utrecht-Medical Oncology ( Site 0037) | Utrecht | 3584 CX | Netherlands | Details |